Layer 1

Why is the GPhC receiving more FTP concerns?

“A large proportion of concerns are likely to be pandemic-related retail concerns”

The massive number of fitness to practise (FtP) concerns the GPhC has received are likely to be the result of the COVID-19 pandemic, says lawyer Andrew Andrews

The number of FtP concerns reported to the General Pharmaceutical Council (GPhC) has risen year on year. This year saw a massive increase in the number of complaints received. The GPhC revealed that it received 380 complaints in March, representing 153 more than it received in March 2019. Then in April, the GPhC reported a 29% increase up to 318 in the concerns it received compared to the same month the previous year.

These reported concerns are then individually triaged. This process may potentially translate into a significant increase in the number of cases that the GPhC investigates, with the more serious of those concerns being referred to the regulator’s FtP committee.

At its meeting on June 11, the GPhC's council was asked to approve its combined 2019-20 annual accounts, annual report and annual statistical FtP report. Once approved and published, the FtP report accompanied by the council’s observations should provide more detailed insight as to the number of concerns raised, matters investigated and cases that have proceeded to hearings.

The GPhC has been working to “develop and implement an intelligence model for managing incoming information”. I believe that the increase in concerns recorded may be somewhat due to the organisation becoming more efficient in the way that it gathers, handles and triages information and intelligence.

COVID-19 has presented unprecedented pressure and challenges for community pharmacy. In the absence of more available statistical data accounting for the significant increase in concerns reported in recent months, I expect that a large proportion of these are likely to be pandemic-related retail concerns.

Some concerns have been well-publicised, attracting negative reputational attention for the sector. These have included such things as the purported high pricing in some pharmacies of face masks and other PPE, hand sanitiser and COVID-19 home-testing kits.

Reported concerns are not always genuine or indicative of any wrongdoing, but investigations and FtP proceedings ordinarily take many months and sometimes years to conclude. They can have potentially serious implications for registered pharmacists or pharmacy technicians, often bringing significant disruption and reputational damage for businesses.

I would always recommend that legal advice is sought at the earliest opportunity. Ideally, from the moment that a pharmacy owner or their employees are first made aware that any concern has been raised against them.

Andrew Andrews is a specialist regulatory compliance lawyer and senior associate within the regulatory compliance team at the law firm VWV


Christopher Jay, Community pharmacist

Could it be that professionalism in pharmacy is at an all time low? Not what many want to hear.

Pharmacy is guilty of not reporting any COVID-19 cases to the HSE, why should we be taken seriously? DISCUSS.




Leon The Apothecary, Student

For the first time in a while, it is my opinion that customers have been told no to various supernumerary demands. Customers who have been used to getting their own way, typically as a favour, then see them being denied extras that they perceived as standard.

I mentioned this before, but I would like to see how many of these complaints and concerns are upheld or dismissed and compare to previous dates.

Chris Locum, Locum pharmacist

Ah yes. I recall a friend who was a manager for a multiple. Head office had received a complaint stating that he "gave the customer a strange look." They are afraid the customer will run away, but it is no problem at all to run the staff literally into the ground for profit.

Benie Locum, Locum pharmacist

Did he lose his job for that? Serious question. I've heard of some pharmacists being reprimanded for being attacked by customers/patients.

Job of the week

Support Pharmacist
Queen Elizabeth Hospital and Heartl
up to £47,500 dependent on hours (30-40 hours flexible)